How to cut HIV incidence? Researchers do the math and find keeping patients in care is pivotal

By on .

Retaining people with HIV in care and treatment for the virus, as well as successful efforts to re-engage patients who have been in care but no longer are would go the furthest toward cutting the numbers of new infections in the United States in half within the next decade, a modeling study reported in Open […]

Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised

By on .

In spite of guidelines and goals, treatment access remains delayed and unequal Data from nearly a million patients starting treatment for HIV across the world over the last decade shows 55 percent of them accessed antiretroviral treatment only after their immune cell — or CD4 — counts had dropped below 200, leaving them extremely vulnerable […]

Infectious diseases doctor sounds an international alarm about HIV treatment resistance in the Philippines

By on .

Visiting IDWeek in October, we met with Dr. Edsel Salvana, an infectious diseases physician from the Philippines who has learned to tell the complicated story of the impacts and implications of the HIV epidemic in his country quickly and clearly. Now, with the online release  of his August 2017 TED Talk, you can see for […]

Survey across seven African countries finds young women and teenage girls less than halfway to 2020 goals for HIV control

By on .

Fewer than half of the adolescent girls and young women living with HIV who were tested for the virus as part of door-to-door surveys across communities in seven African countries were already aware of their infection, according to findings released by the U.S. Centers for Disease Control and Prevention. That’s far short of the 2020 […]

In Guatemala study, illnesses indicating AIDS were already present in about fourth of patients newly diagnosed with HIV

By on .

At Guatemala’s largest HIV clinic, researchers took a retrospective study of current patient records. One in four patients, they found, had an illness indicating advanced progression of the virus at the time they were diagnosed, increasing their risks of other diseases and death, while increasing the costs of their care. With plans now turning to […]

Keeping the balance in how we prevent HIV: Evaluating structural interventions

By on .

The following is a guest post by Jim Thomas, PhD In 1978, the world celebrated the end of smallpox. Through a coordinated multinational effort, a global vaccination program had reached the furthest corners of the earth and eliminated the ability of the virus to spread. The success was intoxicating. Lists of the next diseases to […]

Analysis highlights role of diplomacy in U.S. HIV response leadership, PEPFAR gains

By on .

Conceived as an urgent response to a global health crisis with national security ramifications, the design of the U.S. President’s Emergency Plan for AIDS Relief as a historically ambitious attack on a single disease was unique from the start. In recognition of economic and political factors that had hampered responses to the pandemic at home […]

Analysis: Trump PEPFAR strategy, budget proposals add up to surrender in HIV battle

By on .

White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of countries represents an unprecedented retreat from American leadership of the global fight against the disease and would reverse gains that were achieved, at a cost of more than $80 […]

Medical circumcision efforts gained ground against new HIV infections, but not enough

By on .

Focused efforts to protect men and boys from HIV led to more than 14.5 million medical circumcision procedures globally between 2008 and 2016, enough to avert an estimated half million infections by 2030, according to a report released today. That progress, however, falls at least 30 percent short of the nearly 21 million procedures originally […]

For people with HIV, viral suppression is critical to protection from yellow fever vaccine

By on .

A study on the effectiveness of the yellow fever vaccine among people living with HIV yields yet another reason that universal access to effective consistent antiretroviral medicine for people with the virus is important to global public health. The study, published in the recent Clinical Infectious Diseases found that the yellow fever vaccine offers long-term […]